SAN DIEGO, June 3, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its Board of Directors has approved the spin-off of GRAIL. GRAIL is anticipated to spin off from Illumina on ...

Illumina, Inc. reported financial results for the third quarter of fiscal year 2026, with reported revenue of $1.13 billion, ...

PRNewswire/ -- (Nasdaq: ILMN) ("Illumina" or the "company") today announced its financial results for the third quarter of fiscal year ...

SG-INSIGHT study will extend whole-genome sequencing to nearly 1 in 10 Singapore residents, generating evidence to inform how precision medicine could be implemented in Singapore's healthcare system ...

Shares of Illumina Inc. plunged 18.64% to $235.99 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 1.82% to 7,580.07 and Dow Jones ...

Illumina Inc (NASDAQ:ILMN) reported third-quarter results that exceeded analyst expectations, but shares tumbled 12% in after-hours trading Thursday as investors focused on the company's China revenue ...

Illumina, Inc. reported earnings results for the third quarter and nine months ended September 27, 2026. For the third quarter, the company reported revenue was USD 1,129 million compared to USD 1,084 ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Illumina , Alignment Healthcare and Stryker with bullish sentiments. Illumina (ILM ...

Illumina Inc. announced a profit for its third quarter that Increases, from last year. The company's bottom line came in at $220 million, or $1.43 per share. This compares with $1 ...

GRAIL (GRAL) offers MCED screening tests that offer employers economic value and employee health clarity. Divestiture of GRAIL by Illumina offers investors $8B valuation foundation. TAM valuation ...

This was the stock's fourth consecutive day of gains.